Modulation of Human Immunodeficiency Virus Type 1 Infectivity through Incorporation of Tetraspanin Proteins
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Accumulating evidence indicates that human immunodeficiency virus type 1 (HIV-1) acquires various cellular membrane proteins in the lipid bilayer of the viral envelope membrane. Although some virion-incorporated cellular membrane proteins are known to potently affect HIV-1 infectivity, the virological functions of most virion-incorporated membrane proteins remain unclear. Among these host proteins, we found that CD63 was eliminated from the plasma membranes of HIV-1-producing T cells after activation, followed by a decrease in the amount of virion-incorporated CD63, and in contrast, an increase in the infectivity of the released virions. On the other hand, we found that CD63 at the cell surface was preferentially embedded on the membrane of released virions in an HIV-1 envelope protein (Env)-independent manner and that virion-incorporated CD63 had the potential to inhibit HIV-1 Env-mediated infection in a strain-specific manner at the postattachment entry step(s). In addition, these behaviors were commonly observed in other tetraspanin proteins, such as CD9, CD81, CD82, and CD231. However, L6 protein, whose topology is similar to that of tetraspanins but which does not belong to the tetraspanin superfamily, did not have the potential to prevent HIV-1 infection, despite its successful incorporation into the released particles. Taken together, these results suggest that tetraspanin proteins have the unique potential to modulate HIV-1 infectivity through incorporation into released HIV-1 particles, and our findings may provide a clue to undiscovered aspects of HIV-1 entry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tetraspanin functions and associated microdomains
Hemler, M. E. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1736 · Cited by 1,355 · cited 2×
“CD63 is a type II cellular membrane protein and belongs to the tetraspanin superfamily (32, 62).”
BackgroundA sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes
Cavrois, M., de Noronha, C., & Greene, W. C. (2002) · Nature Biotechnology · doi:10.1038/nbt745 · Cited by 475 · cited 4×
“The HIV-1 fusion assay, which is based on the incorporation of -lactamase–Vpr chimeric proteins (BlaM-Vpr) into virions and subsequent BlaM cleavage of a fluorescent dye (CCF2) present in target cells, was performed as described previously (8).”
MethodInfluentialChertova, E., Chertov, O., Coren, L. V., Roser, J. D., Trubey, C. M., Bess, J. W., Sowder, R. C., Barsov, E., Hood, B. L., Fisher, R. J., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01013-06 · Cited by 462 · cited 2×
“Various host membrane proteins, including CD63 and tetraspanin proteins, exist on HIV-1 particles (7, 9, 45, 46, 55), and some of them affect viral infection.”
BackgroundDirect interaction between the envelope and matrix proteins of HIV-1
Cosson, P. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00964.x · Cited by 211
Cited by
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes
Yáñez-Mó, M., Barreiro, O., Gordon-Alonso, M., Sala-Valdés, M., & Sánchez-Madrid, F. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.06.004 · Cited by 616
Extracellular vesicles and viruses: Are they close relatives?
Nolte-‘t Hoen, E., Cremer, T., Gallo, R. C., & Margolis, L. B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605146113 · Cited by 494
Charrin, S., Jouannet, S., Boucheix, C., & Rubinstein, E. (2014) · Journal of Cell Science · doi:10.1242/jcs.154906 · Cited by 426
Exosomes: Mechanisms of Uptake
McKelvey, K. J., Powell, K. L., Ashton, A. W., Morris, J. M., & McCracken, S. A. (2015) · Journal of Circulating Biomarkers · doi:10.5772/61186 · Cited by 416
Microvesicles and Viral Infection
Meckes, D. G., & Raab-Traub, N. (2011) · Journal of Virology · doi:10.1128/jvi.05853-11 · Cited by 390
Targeting of tetraspanin proteins — potential benefits and strategies
Hemler, M. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2659 · Cited by 345
Weng, J., Krementsov, D. N., Khurana, S., Roy, N. H., & Thali, M. (2009) · Journal of Virology · doi:10.1128/jvi.00163-09 · Cited by 89
Roy, N. H., Lambelé, M., Chan, J., Symeonides, M., & Thali, M. (2014) · Journal of Virology · doi:10.1128/jvi.00550-14 · Cited by 42
EWI-2 Inhibits Cell–Cell Fusion at the HIV-1 Virological Presynapse
Whitaker, E. E., Matheson, N. J., Perlee, S., Munson, P. B., Symeonides, M., & Thali, M. (2019) · Viruses · doi:10.3390/v11121082 · Cited by 27
“We expect that EWI-2 also inhibits the fusion of virus particles to target cells, as tetraspanins do [54,56,59], and we are currently testing that hypothesis (within the context of an extensive follow-up analysis aimed at dissecting the molecular determinants responsible for EWI-2′s fusion-inhibitory”
BackgroundMurakami, T., & Ono, A. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.07.005 · Cited by 16
Metadata
- Authors
- Sato, K., Aoki, J., Misawa, N., Daikoku, E., Sano, K., Tanaka, Y., & Koyanagi, Y.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2008-01-15
- Volume
- 82
- Issue
- 2
- Pages
- 1021-1033
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2002381405
- Cited by
- 122
- References
- 4
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.